Last $24.07 USD
Change Today +1.89 / 8.52%
Volume 2.7M
FMI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Vincent A. Miller M.D.

Chief Medical Officer, Foundation Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 3 different industries.

See Board Relationships
52$613,428
As of Fiscal Year 2013

Background*

Dr. Vincent A. Miller, M.D., has been the Chief Medical Officer at Foundation Medicine, Inc. since July 31,2013 and served its Senior Vice President of Clinical Development since November 1, 2011. Dr. Miller is responsible for driving clinical strategy to support and expand the use of Foundation Medicine's comprehensive cancer genomic test and contributes to the ongoing development of the company's data reporting platform and physician interface. Dr. Miller is a Professor, ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 617-418-2200
Fax: 617-418-2201

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
The University of Pennsylvania
BS
The University of Pennsylvania
MD
University of Medicine and Dentistry of New Jersey

Other Affiliations*

Annual Compensation*

Salary$342,537
Total Annual Compensation$342,537

Stock Options*

All Other Compensation$55,390
Exercisable Options11,716
Exercisable Options Value$261,455
Unexercisable Options63,284
Unexercisable Options Value$1,342,045
Total Value of Options$1,603,500
Total Number of Options75,000

Total Compensation*

Total Annual Cash Compensation$526,810
Total Short Term Compensation$342,537
Other Long Term Compensation$55,390
Total Calculated Compensation$613,428
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FMI:US $24.07 USD +1.89

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$400.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
$649.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNDATION MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.